Cargando…
High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
BACKGROUND: Enhanced glycolysis in tumors, known as the Warburg effect, provides the metabolic basis of enhanced cancer cell proliferation and metastasis. The Warburg pathway enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is a newly identified key kinase that regulates transc...
Autores principales: | Yao, Ling, Wang, Lei, Cao, Zhi-Gang, Hu, Xin, Shao, Zhi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582605/ https://www.ncbi.nlm.nih.gov/pubmed/31244553 http://dx.doi.org/10.1186/s12935-019-0882-2 |
Ejemplares similares
-
Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020) -
High expression of Linc00959 predicts poor prognosis in breast cancer
por: Chi, Weiru, et al.
Publicado: (2019) -
MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis
por: Yao, Guangyu, et al.
Publicado: (2013) -
ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression
por: Li, Kai, et al.
Publicado: (2014) -
B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)